Vivakor expands distribution channels of VivaThermic vials

NewsGuard 100/100 Score

Vivakor, Inc. (OTCBB:VIVK) announced that it has expanded United States distribution of its VivaThermic vials. A listing of Authorized Distributors of VivaThermic vials is available at www.vivathermic.com/distributors. Speaking of its growing network authorized distributors, Dr. Tannin Fuja, Vivakor's CEO and Chief Scientific Officer, said, "We are proud of the strong group of premier distributors we work with to accelerate the delivery of Vivakor technologies to markets throughout the world to our customers who have come to expect the high quality of Vivakor's superior products." 

Matt Nicosia, Executive Chairman of Vivakor, explained, "Management's efforts to commercialize Vivakor Technology and execute its business model are shown by our growing distribution channels. The company continues to seek out the very best commercialization partners to take Vivakor Technology to market. This is our mission and proof of management's vision is in the execution of such commercialization."  

Additionally, VivaThermic technologies are being marketed as the best bio-consumable container for biological and stem cell related reagents which must be stored in temperature controlled environments. This announcement continues upon Vivakor's recently released revenue projections for its VivaThermic division estimated at $20 million annually.

Source:

 Vivakor, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking